Eikon Therapeutics, Inc. Common Stock beat EPS estimates 0% of the time across 2 reported quarters (0 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-1.61 | $-1.63 | -1.2% | Miss |
| Q12026 FY2026 | $-1.47 | $-2.46 | -67.3% | Miss |
Back to EIKN overview · EIKN holders · EIKN KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.